Cytek Biosciences, Inc. (CTKB) vs Helus Pharma Inc. (HELP)
A side-by-side comparison of Cytek Biosciences, Inc. and Helus Pharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTKB
Cytek Biosciences, Inc.
$5.59HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
HELP
Helus Pharma Inc.
$10.79HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Total return — CTKB vs HELP
growth of $100 · dividends reinvested · last 1yCTKB +22.0% (+22.0%/yr)HELP +93.2% (+93.2%/yr)HELP compounded faster over this window
CTKB HELP
CTKB vs HELP: by the numbers
- •CTKB is the larger company ($721M vs $668M market cap).
- •HELP is profitable (329.09% net margin) while CTKB runs a net loss (-38.98%).
Metrics side by side
Valuation
| Metric | CTKB | HELP |
|---|---|---|
| P/S ratio | 3.49 | N/A |
| P/B ratio | 2.24 | 2.76 |
Profitability
| Metric | CTKB | HELP |
|---|---|---|
| Gross margin | 53.23% | 100.27% |
| Operating margin | -21.60% | 317.06% |
| Net margin | -38.98% | 329.09% |
| ROE | -25.03% | -75.79% |
| ROIC | -12.00% | -73.27% |
Growth (annualized)
| Metric | CTKB | HELP |
|---|---|---|
| Revenue CAGR (5Y) | 13.37% | N/A |
| Total return CAGR (5Y) | -23.16% | N/A |
Frequently asked
- Is CTKB or HELP more profitable?
- HELP runs the higher net margin — CTKB at -38.98% versus HELP at 329.09%.
Go deeper
Dig into the metrics
Cytek Biosciences ROEHelus Pharma ROECytek Biosciences operating marginHelus Pharma operating marginCytek Biosciences revenue growthHelus Pharma revenue growthCytek Biosciences free cash flowHelus Pharma free cash flow
Cytek Biosciences & Helus Pharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.